Alliance Global Partners says Trulieve Cannabis (TCNNF) is best positioned after the Florida State Supreme Court ruled that a measure to legalize adult-use marijuana in the state will be allowed on the November ballot. The state of Florida requires 60% approval for passage, with polls giving mixed indications, and generally within the margin of error for passing, the analyst tells investors in a research note. The firm sees “market leader” Trulieve as best positioned, along with Curaleaf (CURLF) and Verano (VRNOF) “as leaders in the current medical market,” with Green Thumb (GTBIF), Cresco (CRLBF) and Cannabist Company (CBSTF) having a smaller presence in the state as of today.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TCNNF:
- Rising High: Exclusive talk with financial services firm Safe Harbor Financial
- Trulieve Expands with New Florida Dispensary
- Cannabis Stocks Surge as Schumer Increases Push for SAFER Banking Act
- Cannabis stocks rally after Germany passes partial legalization law
- Here’s What You Missed in Cannabis, Psychedelics This Week